Mitch C.  Hill net worth and biography

Mitch Hill Biography and Net Worth

Mitch has extensive experience leading financial functions at both large and small companies. With senior executive experience at a number of private equity and venture capital-backed companies in medical device and health care services, Mitch has led many organizations to scale their financial strategies during rapid growth, such as Cameron Health which was acquired by BSX and Visiogen which was acquired by ABT. Prior to entering the health care industry, served as CFO of Walt Disney Imagineering and as President and CFO of Buy.com, Inc., including at the time of its initial public offering in February 2000. Mitch brings a wealth of financial knowledge and experience from high growth industries and an understanding of the challenges and landscape of modern healthcare. He earned a BS in Accounting from Brigham Young Univ. and an MBA from Harvard Business School.

What is Mitch C. Hill's net worth?

The estimated net worth of Mitch C. Hill is at least $9.96 million as of September 12th, 2024. Mr. Hill owns 179,600 shares of Inari Medical stock worth more than $9,958,820 as of December 21st. This net worth approximation does not reflect any other assets that Mr. Hill may own. Learn More about Mitch C. Hill's net worth.

How do I contact Mitch C. Hill?

The corporate mailing address for Mr. Hill and other Inari Medical executives is 9 Parker Suite 100, Irvine CA, 92618. Inari Medical can also be reached via phone at 877-923-4747 and via email at [email protected]. Learn More on Mitch C. Hill's contact information.

Has Mitch C. Hill been buying or selling shares of Inari Medical?

Mitch C. Hill has not been actively trading shares of Inari Medical over the course of the past ninety days. Learn More on Mitch C. Hill's trading history.

Who are Inari Medical's active insiders?

Inari Medical's insider roster includes Rebecca Chambers (Director), Mitch Hill (CFO), William Hoffman (CEO), Andrew Hykes (CEO, President & Director), Donald Milder (Director), Kirk Nielsen (Director), and Thomas Tu (Insider). Learn More on Inari Medical's active insiders.

Are insiders buying or selling shares of Inari Medical?

In the last year, insiders at the sold shares 26 times. They sold a total of 562,744 shares worth more than $27,798,968.16. The most recent insider tranaction occured on December, 20th when CEO Andrew Hykes sold 3,000 shares worth more than $165,870.00. Insiders at Inari Medical own 10.6% of the company. Learn More about insider trades at Inari Medical.

Information on this page was last updated on 12/20/2024.

Mitch C. Hill Insider Trading History at Inari Medical

See Full Table

Mitch C. Hill Buying and Selling Activity at Inari Medical

This chart shows Mitch C. Hill's buying and selling at Inari Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Inari Medical Company Overview

Inari Medical logo
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $55.45
Low: $53.49
High: $55.82

50 Day Range

MA: $50.12
Low: $42.20
High: $58.21

2 Week Range

Now: $55.45
Low: $36.73
High: $66.61

Volume

1,874,948 shs

Average Volume

998,000 shs

Market Capitalization

$3.25 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.97